Surgical Management of Abnormalities in Cervical Neoplasia

来源 :The 6th Biennial Conference of Asia Oceania Research Organis | 被引量 : 0次 | 上传用户：coolyina

【摘要】

：

Cervical Neoplasia ranged from pre-invasive to invasive lesions.In the management of abnormal cervical intraepithelial neoplasia (CIN), it started with investigations of abnormal cervical cytology by

【作者】

：

HYS Ngan

【机构】

：

Department of Obstetrics & Gynaecology,University of Hong Kong,Queen Mary Hospital,Hong Kong,SAR,Chi

【出处】

：

The 6th Biennial Conference of Asia Oceania Research Organis

【发表日期】

：

2014年2期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Cervical Neoplasia ranged from pre-invasive to invasive lesions.In the management of abnormal cervical intraepithelial neoplasia (CIN), it started with investigations of abnormal cervical cytology by colposcopy and biopsy.

其他文献

ROLE OF ISSVD IN VIN DEFINITION

Preinvasive neoplasia of the vulva has been recognized for over 90 years, but terminology to describe this disease has been confusing.

会议

Safety, pharmacokinetics and efficacy phase ii-a study of AP611074,a HPV-specific treatment for cond

Objectives: AP611074 is a new drug that inhibits the interaction of E1/E2 proteins of HPV6/11, blocking HPV replication.We aimed to obtain proof-of-concept of AP611074 in the topical treatment of cond

会议

HPVantiviral drugcondylomaano-genital warts

Does the HPV-16/18 AS04-adjuvanted vaccine benefit women with cervical disease and dose it have effi

Objectives:We investigated whether women who underwent subsequent cervical excision during the PATRICIA trial (AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine) benefited from reduced incidenc

会议

THE ROLE OF CERVISTA HR HPV TEST IN CERVICAL CANCER SCREENING, A CROSS-SECTIONAL STUDY OF CLINICAL A

Background: The type distribution of high-risk (HR) HPV types associated with cervical neoplasia is somewhat different in China compared to that of Europe or North America, with the most prevalent typ

会议

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursor

The objectives of the protocol (Cochrane Database of Systematic Reviews 2013, Issue 12.Art.No.: CD009069.DOI: 10.1002/14651858.CD009069.pub2), are as follows:To evaluate the immunogenicity, clinical e

会议

Cytology and HPV co-testing of cervical cancer in China

It is well known that high risk HPV infection is the leading cause of cervical cancer.HPV testing has been applied in cervical cancer screening, and the hybrid capture Ⅱ (HCⅡ) testing has been used in

会议

Histopathology of Precancerous Lesions of the Cervix

Precancerous lesions of the cervix include squamous and glandular lesions.The former include low grade and high grade squamous intraepithelial lesions whereas the latter include glandular dysplasia an

会议

Cervical Cancer Screening after Introduction of HPV Vaccines

Cervical cytology test has been used for cervical cancer screening program for decades,successfully leading to significant reduction in the incidence of invasive cervical cancer.New approaches have be

会议

Management of glandular abnormalities in cervical smears

Glandular abnormalities represent a smal1 percentage of all abnormal cervical smears but are associated with a significant underlying neoplasia rate of up to 50％.

会议

Feasibility study of careHPV detection in Xinjiang Uyghur women

Objective: to evaluate feasibility of careHPV testing by comparing with liquid-based cytology, search for suitable screening method for rural China.

会议

care HPVXinjiangcervical cancerscreen

Surgical Management of Abnormalities in Cervical Neoplasia

其他学术论文